José Bellver

José Bellver

Auto-generated profile, based on publicly available information

José Bellver

Instituto Valenciano de Infertilidad (IVI), University of Valencia, Plaza de la Policía Local, 3, 46015 Valencia, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Fertility and Sterility
Verified
Journal Article
Closed access
JBJosé Bellver
José Bellver
YAYanira Ayllón
Yanira Ayllón
MFMarcos Ferrando
Marcos Ferrando
MMMarco Melo
Marco Melo
EGEduardo Goyri
Eduardo Goyri
MMMarcos Meseguer
Marcos Meseguer

1 August 2007 in Fertility and Sterility
Verified
Journal Article
Closed access
JBJosé Bellver
José Bellver
MMMarco A.B. Melo
Marco A.B. Melo
EBErnesto Bosch
Ernesto Bosch
VSVicente Serra
Vicente Serra
JRJosé Remohí
José Remohí
APAntonio Pellicer
Antonio Pellicer

1 June 2011 in Fertility and Sterility
Verified
Journal Article
Closed access
JBJosé Bellver
José Bellver
JMJosé Antonio Martínez-Conejero
José Antonio Martínez-Conejero
ELElena Labarta
Elena Labarta
PAPilar Alamá
Pilar Alamá
MMMarco Antonio Barreto Melo
Marco Antonio Barreto Melo
JHJosé Antonio Horcajadas
José Antonio Horcajadas

10 December 2007 in Human Reproduction
Verified
Journal Article
Open access
PDF file
JBJosé Bellver
José Bellver
SSSergio R. Soares
Sergio R. Soares
CÁClaudio Álvarez
Claudio Álvarez
EMElkin Muñoz
Elkin Muñoz
ARAlberto Ramírez
Alberto Ramírez
APAntonio Pellicer
Antonio Pellicer
The role of thrombophilia and thyroid autoimmunity in unexplained infertility (UI), implantation failure (IF) and recurrent spontaneous abortion (RSA) is controversial and poorly understood. From March, 2004 to January, 2007, 119 women were prospectively included: 32 oocyte donors, 31 patients with UI, 26 with IF and 30 with RSA. The IF and RSA groups presented normal preimplantation genetic screening. Protein C, protein S, antithrombin III, lupus anticoagulant, activated protein C resistance (APCR), immunoglobulin M and G anticardiolipin antibodies, homocystine, Factor V Leiden, prothrombin G20210A mutation, methylentetrahydrofolate reductase C677T mutation, thyroid-stimulating hormone (TSH), free thyroxine, anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TG) antibodies were assessed. The prevalence of thrombophilia was high and similar among groups. In the IF group, the prevalence of APCR (15.4%), lupus anticoagulant (11.5%) and combined thrombophilia (19.2%) was higher, but not significantly different, than the other three groups. The prevalence of thyroid autoimmunity in women with IF (anti-TPO antibodies, P = 0.009; anti-TPO plus anti-TG antibodies,P = 0.04) and UI (anti-TPO, P = 0.002; anti-TG, P = 0.019; anti-TPO plus anti-TG antibodies, P = 0.005) was significantly increased in comparison to those with RSA. There was also a trend towards a higher prevalence of thyroid autoimmunity in the UI and IF groups than in the control group. TSH and free thyroxine levels all remained within a normal range. When embryo aneuploidy is ruled out, thrombophilia could constitute an etiologic factor in IF. Furthermore, thyroid autoimmunity is strongly related to UI and IF.

1 January 2008 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
JBJose Bellver
Jose Bellver
NGNicolas Garrido
Nicolas Garrido
JRJose Remohí
Jose Remohí
APAntonio Pellicer
Antonio Pellicer
MMMarcos Meseguer
Marcos Meseguer